Novel fatty acid metabolism-related molecular subtyping and prognostic signature for breast cancer | Synapse
March 3, 2026Open Access
Novel fatty acid metabolism-related molecular subtyping and prognostic signature for breast cancer
Puntos clave
FAMGM is identified as a significant prognostic marker in breast cancer, improving treatment options and outcomes.
The prognostic value may lead to better mechanisms for diagnosing and understanding breast cancer pathology.
Analysis utilizes fatty acid metabolism-related molecular subtyping to create a new framework for assessing breast cancer prognosis.
This research indicates potential advancements in treatment strategies for patients, emphasizing the importance of novel biomarkers.
Resumen
FAMGM holds significant potential as a prognostic marker and could be used in the subsequent diagnosis, treatment, prognostic prediction, and mechanistic research of BRCA.